Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

7 papers

Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)

G. Mion, Thierry Villevieille
CNS Neuroscience & Therapeutics Summary & key facts 2013 656 citations

Ketamine has been used as a safe anesthetic for more than 50 years and also works well for pain relief. The active form is S(+)-ketamine and it is mainly broken down into an active metabolite called norketamine. Ketamine blocks NMDA receptors in the brain, which helps explain its special effects…

Anesthesia and Neurotoxicity Research Anesthesia and Sedative Agents Treatment of Major Depression

Ketamine for chronic pain: risks and benefits

Marieke Niesters, Christian Martini, Albert Dahan

Ketamine, an anaesthetic, can reduce chronic pain, especially pain with nerve damage. Low doses give strong pain relief, probably by blocking NMDA receptors. Short infusions tend to help only while the drug is given, but three studies found that longer infusions (4–14 days) produced pain relief lasting up to 3…

Anesthesia and Sedative Agents Pain Mechanisms and Treatments Treatment of Major Depression

Ketamine: Current applications in anesthesia, pain, and critical care

Madhuri S Kurdi, Kaushic A Theerth, Radhika S Deva
PubMed Central (PMC) Summary & key facts 2014 379 citations

This 2014 review describes how ketamine, an anesthetic first sold in 1970, is used today in anesthesia, pain care, and critical care. The paper says ketamine has many effects: it can raise heart rate and blood pressure, relax airways, spare breathing, and block NMDA receptors. Newer research reported possible neuroprotective,…

Anesthesia and Neurotoxicity Research Anesthesia and Pain Management Anesthesia and Sedative Agents

Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?

Chittaranjan Andrade

Researchers reviewed many studies on ketamine for depression and found that we still do not have firm answers about the best dose, how fast to give it, which way to give it, how long to treat, or how often to give treatments. Most studies used 0.5 mg/kg given over about…

Anesthesia and Sedative Agents Electroconvulsive Therapy Studies Treatment of Major Depression

Oral Ketamine for Children with Chronic Pain: A Pilot Phase 1 Study

Amy‐Lee Bredlau, Michael McDermott, Heather Adams, Robert H. Dworkin, Charles S. Venuto, Susan G. Fisher, et al.
The Journal of Pediatrics Summary & key facts 2013 45 citations

Twelve children (ages 8–21) with chronic pain received oral ketamine three times a day for 14 days at doses between 0.25 and 1.5 mg/kg per dose to test short-term safety and see if pain improved. Two children at the highest dose (1.5 mg/kg) had dose-limiting side effects (sedation and anorexia),…

Anesthesia and Neurotoxicity Research Anesthesia and Sedative Agents Pediatric Pain Management Techniques

Efficacy and Safety of Intranasal Ketamine for Acute Pain Management in the Emergency Setting: A Systematic Review and Meta-Analysis

Yee Sin Seak, Junainah Nor, Tuan Hairulnizam Tuan Kamauzaman, A Arithra, Md Asiful Islam
Journal of Clinical Medicine Summary & key facts 2021 27 citations

This systematic review and meta-analysis pooled seven randomized trials with 1760 adults seen in emergency departments (search to 21 May 2021). It found no clear difference in short-term pain scores between intranasal (IN) ketamine and IV analgesics or placebo at 5, 15, 25, 30, and 60 minutes. The need for…

Anesthesia and Pain Management Anesthesia and Sedative Agents Pediatric Pain Management Techniques

Esketamine has promising anti-inflammatory effects in orthopedic surgery and plays a protective role in postoperative cognitive function and pain management

Lichun Han

Researchers gave a low dose of esketamine through an IV before general anesthesia to 200 adults having planned orthopedic surgery. They compared 100 people who got esketamine with 100 who got a saline placebo. The esketamine group showed smaller rises in inflammatory proteins after surgery, higher levels of antibodies, less…

Anesthesia and Neurotoxicity Research Anesthesia and Sedative Agents Treatment of Major Depression Ketamine
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.